[In recent years, GPR40 agonists have been investigated for use as novel therapeutic agents in the treatment of type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE